PartsTable
Technical Data Sheet
Download PDF

NDC00409-9094-31 — FENTANYL CITRATE INJECTION

✓ Government record, cited
— · COMPONENT
PRODUCT OVERVIEW

NDC00409-9094-31: FENTANYL CITRATE INJECTION.

The FENTANYL CITRATE INJECTION is a the manufacturer industrial component. Key specifications include primary_container_type: VIAL, SINGLE DOSE, secondary_container_type: PACKAGE, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 25, primary_container_content_quantity: 20.0 MILLILITERS, controlled_substance_classification: SCHEDULE II. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-696-3087, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS
NDC00409-9094-31
NSN: 6505-01-696-3087
FSC: 6505 — Drugs and Biologicals
CAGE: 72QE3 — HOSPIRA WORLDWIDE LLC (USA)
SPECIFICATIONS
special_featuresFENTANYL (PF) 50 MCG/ML INJECTION SOLUTION 20ML C-II. PRESERVATIVE FREE FORMULATION. CONTROLLED SUBSTANCE. STORE AT 20 TO 25 C (68 TO 77 F)
primary_container_typeVIAL, SINGLE DOSE
secondary_container_typePACKAGE
medical_designation_and_gradeUNITED STATES PHARMACOPEIA
total_primary_container_quantity25
primary_container_content_quantity20.0 MILLILITERS
controlled_substance_classificationSCHEDULE II
active_medicament_medicinal_strength50.0 MICROGRAMS FENTANYL CITRATE PER MILLILITER
part_name_assigned_by_controlling_agencyFENTANYL 1,000 MCG/20 ML VIAL 20ML 25EA
NSN6505-01-696-3087
COMPONENT DIAGRAM
COMPONENT MAIN IC EDGE CONNECTOR No detailed specs available FENTANYL CITRATE INJECTION TITLE COMPONENT PN NDC00409-9094-31 MFR FENTANYL CITRATE INJEC
KEY FEATURES
•
CONTROLLED SUBSTANCE CLASSIFICATION: SCHEDULE II
•
PRIMARY CONTAINER CONTENT QUANTITY: 20.0 MILLILITERS
•
SECONDARY CONTAINER TYPE: PACKAGE
•
MEDICAL DESIGNATION AND GRADE: UNITED STATES PHARMACOPEIA
•
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
•
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.0 MICROGRAMS FENTANYL CITRATE PER MILLILITER
TECHNICAL CHARACTERISTICS
CONTROLLED SUBSTANCE CLASSIFICATIONSCHEDULE II
PRIMARY CONTAINER CONTENT QUANTITY20.0 MILLILITERS
SECONDARY CONTAINER TYPEPACKAGE
MEDICAL DESIGNATION AND GRADEUNITED STATES PHARMACOPEIA
PRIMARY CONTAINER TYPEVIAL, SINGLE DOSE
SPECIAL FEATURESFENTANYL (PF) 50 MCG/ML INJECTION SOLUTION 20ML C-II. PRESERVATIVE FREE FORMULATION. CONTROLLED SUBSTANCE. STORE AT 20 TO 25 C (68 TO 77 F)
PART NAME ASSIGNED BY CONTROLLING AGENCYFENTANYL 1,000 MCG/20 ML VIAL 20ML 25EA
ACTIVE MEDICAMENT MEDICINAL STRENGTH50.0 MICROGRAMS FENTANYL CITRATE PER MILLILITER
TOTAL PRIMARY CONTAINER QUANTITY25
OTHER ITEMS IN FSC 6505 — Drugs and Biologicals
Items in the same Federal Supply class. No interchangeability or substitution relationship is implied.
6505-00-000-0073 6505-00-000-0110 6505-00-000-0134 6505-00-000-0135 6505-00-001-3344 6505-00-001-3345 6505-00-001-3346 6505-00-001-3347
SUBSTITUTES & CROSS-REFERENCES 2
6505NCM217240Reference document
Same NSN cross-reference
Reference document — Secondary reference
1599102Reference document
Same NSN cross-reference
Reference document — Secondary reference
LIFECYCLE
NSN statusActive· U.S. Government catalog
Shelf-life managedNo demilitarization required
Ready to buy NDC00409-9094-31?
Compare prices from verified sellers on eBay
Buy on eBay →
As an eBay Partner, PartsTable may earn a commission. Your price is not affected.
FREQUENTLY ASKED QUESTIONS
What is NDC00409-9094-31?
NDC00409-9094-31 is a FENTANYL CITRATE INJECTION.
What parts can replace NDC00409-9094-31?
There are 2 known substitutes for NDC00409-9094-31: 6505NCM217240, 1599102. Substitute compatibility should be verified for your specific system.
What is the NSN for NDC00409-9094-31?
NDC00409-9094-31 is cataloged in the U.S. Government catalog under NSN 6505-01-696-3087. This indicates validated use in U.S. government and defense supply chains.
Community Feedback
Leave a Comment
Comments are reviewed before appearing. You will receive an email to verify before your comment appears.

Request a Quote — NDC00409-9094-31